NEW YORK (GenomeWeb) – GenMark Diagnostics today reported a 34 percent increase year over year in its third quarter revenues, but the firm has moved back the European launch of its ePlex sample-to-answer system.

For the three months ended Sept. 30, GenMark's total revenues increased to $8.5 million from $ 6.3 million in the prior-year period. The firm beat the average Wall Street estimate of $8.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.